Rwanda Launches Africa's First Trial of Long-Acting Malaria Prevention Injection
Originally published by AllAfrica News: Kenya — Read the original article →
[Capital FM] Nairobi — Rwanda has launched Africa’s first clinical trial of a long-acting injectable drug for malaria prevention, marking a potential shift in how the disease is prevented as drug resistance and climate change threaten progress against the mosquito-borne illness.